Sage Therapeutics Ratios and Metrics

Market cap in millions TZS. Fiscal year is January - December.

Millions TZS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	3,160,325	1,749,932	1,201,446	1,031,676	731,315	509,309	Upgrade
Market Cap Growth	53.85%	45.65%	16.46%	41.07%	43.59%	105.26%	Upgrade
Last Close Price	1210.00	619.36	387.27	302.61	196.12	126.40	Upgrade
PE Ratio	5.04	3.16	2.83	2.94	2.73	3.08	Upgrade
PS Ratio	1.86	1.15	0.97	0.98	0.81	0.69	Upgrade
PB Ratio	1.32	0.81	0.67	0.70	0.60	0.50	Upgrade
Debt / Equity Ratio	1.17	1.44	1.28	0.44	0.19	0.30	Upgrade
Return on Equity (ROE)	28.75%	27.89%	25.93%	26.05%	24.05%	17.54%	Upgrade
Return on Assets (ROA)	3.59%	3.67%	3.39%	3.44%	3.36%	2.40%	Upgrade
Earnings Yield	19.81%	31.68%	35.35%	34.06%	36.67%	32.43%	Upgrade
FCF Yield	-86.40%	-69.26%	-71.62%	-230.96%	-138.98%	-57.84%	Upgrade
Dividend Yield	5.37%	10.50%	12.91%	14.87%	18.36%	17.41%	Upgrade
Payout Ratio	46.58%	22.98%	27.16%	26.16%	21.46%	26.88%	Upgrade
Buyback Yield / Dilution	0.47%	-	-	-	-	-	Upgrade
Total Shareholder Return	6.02%	10.50%	12.91%	14.87%	18.36%	17.41%	Upgrade

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.